Progesterone enhances differentiation of primary human osteoblasts in long-term cultures: The influence of concentration and cyclicity of progesterone on proliferation and differentiation of human osteoblasts in vitro;Progesteron verstärkt die differenzierung primärer humaner osteoblasten in langzeit-kulturen: Der einfluss von konzentration und zyklizität von progesteron auf die proliferation und differenzierung humaner osteoblasten in vitro

Geburtshilfe und Frauenheilkunde

Volumn 68, Issue 7, 2008, Pages 722-728

  Schmidmayr, M ^a   Magdolen, U ^b   Tubel J ^b   Kiechle, M ^a   Burgkart, R ^b   Seifert Klauss, Vanadin ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Differentiation; Estradiol; Osteoblast; Perimenopause; Progesterone

Indexed keywords

ALKALINE PHOSPHATASE; BETA N ACETYLHEXOSAMINIDASE; ESTRADIOL; ESTROGEN; PROGESTERONE;

ARTICLE; BIOSYNTHESIS; BONE DENSITY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLIMACTERIUM; CONTROLLED STUDY; ENZYME ASSAY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; OSTEOBLAST; OSTEOLYSIS;

EID: 49649128375     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038711     Document Type: Article

References (23)

1. Seifert-Klauss V, Laakmann J, Rattenhuber J, Höß C, Luppa P, Kiechle M. Knochenstoffwechsel, Knochendichte und Östrogenspiegel in der Perimenopause: eine prospektive 2-Jahres-Untersuchung. Zentralblatt für Gynäkologie 2005; 127: 132-139
2. Seifert-Klauss V, Link TM, Heumann C, Luppa P, Haseitl M, Rattenhuber J, Kiechle M. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas 2006; 55: 317-324
3. Sun L, Peng Y, Sharrow AC, Iqubal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu L-L, Yaroslavskij BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M. FSH directly regulates bone mass. Cell 2006; 125: 247-260
4. Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. New England Journal of Medicine 1990; 323: 1221-1227
5. Prior JC. Progesterone as a bone trophic hormone. Endocrine Reviews 1990; 11: 386-398
6. Hadji P, Rabe T, Ortmann O, Mueck AO, von Holst T, Emons G, Schulz K-D. Möglichkeiten und Grenzen der Osteoporoseprävention durch Östrogene und Gestagene. Geburtsh Frauenheilk 2002; 62: 436-445
7. Luo X-H, Liao E-Y, Su X. Progesterone upregulates TGF-β isoforms (β1, β2 and β3) expression in normal human osteoblast-like cells. Calcif Tissue Int 2002; 71: 329-334
8. Katzburg S, Lieberherr M, Ornoy A, Klein BY, Hendel D, Somjen D. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: Gender and age differences. Bone 1999; 25: 667-673
9. Scheven BAA, Damen CA, Hamilton NJ, Verhaar HJJ, Duursma SA. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochemical and Biophysical Research Communications 1992; 186: 54-60
10. Rickard JD, Waters KM, Ruesink TJ, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Riggs BL, Spelsberg TC. Estrogen receptor isoform-specific induction of progesterone receptors in osteoblasts. JBMR 2002; 17: 580-591
11. Verhaar HJ. Comparison of the action of 17-β-estradiol and progestins with insulin-like growth factor -I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells. Maturitas 1995; 21: 237-243
12. Ishida Y, Killinger DW, Khal MW, Yang K, Strutt B, Heersche JNM. Expression of steroid converting enzymes in osteoblasts derived from rat vertebrae. Osteoporosis Int 2002; 13: 235-240
13. Ishida Y, Heersche JNM. Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: An hypothesis. Osteoporosis International 2002; 13: 601-605
14. Rickard JD, Waters KM, Ruesink TJ, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Riggs BL, Spelsberg TC. Estrogen receptor isoform-specific induction of progesterone receptors in osteoblasts. JBMR 2002; 17: 580-591
15. Ernst M, Schmid C, Froesch ER. Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and unterus of rats in vivo. J Steroid Biochem 1989; 33: 907-914
16. Scheven BAA, Damen CA, Hamilton NJ, Verhaar HJJ, Duursma SA. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochemical and Biophysical Research Communications 1992; 186: 54-60
17. Rao LG, Murray TM. Studies of human osteoblasts in vitro: Estrogen actions and interactions with other hormones at different stages of differentiation. Drug development research 2000; 49: 174-186
18. Katzburg S, Lieberherr M, Ornoy A, Klein BY, Hendel D, Somjen D. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: Gender and age differences. Bone 1999; 25: 667-673
19. Hellmeyer M, Hadji P, Ziller V, Wagner U, Schmidt S. Osteoporose in der Schwangerschaft. Geburtsh Frauenheilk 2004; 64: 38-45
20. Viereck V, Gründker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch K, Raddatz D, Emons G, Hofbauer LC. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6-production by human trabecular osteoblasts. The Journal of Clinical Endocrinology and Metabolism 2003; 88: 4206-4213
21. Slootweg MC, Ederveen AGH, Schot LPC, Schoonen WGEJ, Kloosterboer HJ. Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation. Journal of Endocrinology 1992; 133: R5-R8
22. Bowman BM, Miller SC. Elevated progesterone during pseudopregnancy may prevent bone loss associated with low estrogen. J Bone Miner Res 1996; 11: 15-21
23. Tang OS, Tang G, Yip P, Li B, Fan S. Long-term depot-medroxyprogesterone acetate and bone mineral density. Contraception 1999; 59: 25-29